Final results from the INO-VATE ALL study of inotuzumab ozogamicin
Final findings from the Phase III INO-VATE ALL evaluating the safety and efficacy of inotuzumab ozogamicin in acute lymphoblastic leukaemia (ALL) have been announced.
Click on this link for more information.
